Victory Capital Management Inc Aerie Pharmaceuticals Inc Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$12.0 - $16.13 $78,168 - $105,070	-6,514 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$11.84 - $25.52 $21,975 - $47,365	-1,856 Reduced 22.17%	6,514 $88,000
Q4 2019 Feb 06, 2020	BUY	$17.72 - $25.1 $30,513 - $43,222	1,722 Added 25.9%	8,370 $202,000
Q4 2019 Feb 04, 2020	SELL	$17.72 - $25.1 $8,204 - $11,621	-463 Reduced 6.51%	6,648 $136,000
Q3 2019 Nov 12, 2019	BUY	$18.41 - $28.0 $130,913 - $199,108	7,111 New	7,111 $137,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.